Thyreos Receives Funding for HSV-2 Vaccine Development

Thyreos, a member of Bio Nebraska, announced that it has closed a $1 million series seed b round of financing and has been awarded a $1.6 million Small Business Technology Transfer Fast-Track grant from the National Institutes of Health National Institute of Allergy and Infectious Diseases for the development of an HSV-2 vaccine. Read more